Cargando…

Positive Influence of Being Overweight/Obese on Long Term Survival in Patients Hospitalised Due to Acute Heart Failure

BACKGROUND: Obesity is clearly associated with increased morbidity and mortality rates. However, in patients with acute heart failure (AHF), an increased BMI could represent a protective marker. Studies evaluating the “obesity paradox” on a large cohort with long-term follow-up are lacking. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Littnerova, Simona, Parenica, Jiri, Spinar, Jindrich, Vitovec, Jirí, Linhart, Ales, Widimsky, Petr, Jarkovsky, Jiri, Miklik, Roman, Spinarova, Lenka, Zeman, Kamil, Belohlavek, Jan, Malek, Filip, Felsoci, Marian, Kettner, Jiri, Ostadal, Petr, Cihalik, Cestmir, Spac, Jiri, Al-Hiti, Hikmet, Fedorco, Marian, Fojt, Richard, Kruger, Andreas, Malek, Josef, Mikusová, Tereza, Monhart, Zdenek, Bohacova, Stanislava, Pohludkova, Lidka, Rohac, Filip, Vaclavik, Jan, Vondrakova, Dagmar, Vyskocilova, Klaudia, Bambuch, Miroslav, Dusek, Ladislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339191/
https://www.ncbi.nlm.nih.gov/pubmed/25710625
http://dx.doi.org/10.1371/journal.pone.0117142
Descripción
Sumario:BACKGROUND: Obesity is clearly associated with increased morbidity and mortality rates. However, in patients with acute heart failure (AHF), an increased BMI could represent a protective marker. Studies evaluating the “obesity paradox” on a large cohort with long-term follow-up are lacking. METHODS: Using the AHEAD database (a Czech multi-centre database of patients hospitalised due to AHF), 5057 patients were evaluated; patients with a BMI <18.5 kg/m(2) were excluded. All-cause mortality was compared between groups with a BMI of 18.5–25 kg/m(2) and with BMI >25 kg/m(2). Data were adjusted by a propensity score for 11 parameters. RESULTS: In the balanced groups, the difference in 30-day mortality was not significant. The long-term mortality of patients with normal weight was higher than for those who were overweight/obese (HR, 1.36; 95% CI, 1.26–1.48; p<0.001)). In the balanced dataset, the pattern was similar (1.22; 1.09–1.39; p<0.001). A similar result was found in the balanced dataset of a subgroup of patients with de novo AHF (1.30; 1.11–1.52; p = 0.001), but only a trend in a balanced dataset of patients with acute decompensated heart failure. CONCLUSION: These data suggest significantly lower long-term mortality in overweight/obese patients with AHF. The results suggest that at present there is no evidence for weight reduction in overweight/obese patients with heart failure, and emphasize the importance of prevention of cardiac cachexia.